nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—Lamotrigine—ABCB1—adrenal gland cancer	0.28	1	CrCbGaD
Pyrimethamine—DHFR—Nucleotide Metabolism—RRM1—adrenal gland cancer	0.143	0.199	CbGpPWpGaD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.092	0.128	CbGpPWpGaD
Pyrimethamine—DHFR—E2F transcription factor network—RRM1—adrenal gland cancer	0.0487	0.0677	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.0423	0.0588	CbGpPWpGaD
Pyrimethamine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0314	0.0435	CbGpPWpGaD
Pyrimethamine—DHFR—E2F mediated regulation of DNA replication—RB1—adrenal gland cancer	0.0265	0.0368	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.0262	0.0363	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.0184	0.0256	CbGpPWpGaD
Pyrimethamine—DHFR—E2F transcription factor network—RB1—adrenal gland cancer	0.014	0.0195	CbGpPWpGaD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.013	0.018	CbGpPWpGaD
Pyrimethamine—DHFR—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.0123	0.0171	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.0122	0.0169	CbGpPWpGaD
Pyrimethamine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0103	0.0142	CbGpPWpGaD
Pyrimethamine—DHFR—G1/S Transition—RB1—adrenal gland cancer	0.0102	0.0141	CbGpPWpGaD
Pyrimethamine—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—adrenal gland cancer	0.01	0.0139	CbGpPWpGaD
Pyrimethamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00977	0.0136	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.00858	0.0119	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.00754	0.0105	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—TP53—adrenal gland cancer	0.00744	0.0103	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.00675	0.00937	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SH3KBP1—adrenal gland cancer	0.00661	0.00918	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—SDHB—adrenal gland cancer	0.00651	0.00905	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ZNRF3—adrenal gland cancer	0.00622	0.00863	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TOP2A—adrenal gland cancer	0.00604	0.00838	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.00597	0.00829	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.00594	0.00825	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—PRKACA—adrenal gland cancer	0.00531	0.00738	CbGpPWpGaD
Pyrimethamine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00523	0.00726	CbGpPWpGaD
Pyrimethamine—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00482	0.0067	CbGpPWpGaD
Pyrimethamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00429	0.00596	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00426	0.00591	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00424	0.00589	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—SDHD—adrenal gland cancer	0.0042	0.00583	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—RRM1—adrenal gland cancer	0.0042	0.00583	CbGpPWpGaD
Pyrimethamine—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00393	0.00545	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SPRY2—adrenal gland cancer	0.0039	0.00541	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TERT—adrenal gland cancer	0.00362	0.00502	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MEN1—adrenal gland cancer	0.00357	0.00496	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00348	0.00483	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00345	0.00479	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.00315	0.00437	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—MED12—adrenal gland cancer	0.00313	0.00435	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—RB1—adrenal gland cancer	0.00281	0.00391	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.00277	0.00384	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PRKACA—adrenal gland cancer	0.00273	0.00379	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—CDKN2A—adrenal gland cancer	0.00247	0.00344	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDC42—adrenal gland cancer	0.00231	0.00321	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PRKACA—adrenal gland cancer	0.00228	0.00317	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.00225	0.00313	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00217	0.00302	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SDHB—adrenal gland cancer	0.00201	0.0028	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TERT—adrenal gland cancer	0.00185	0.00258	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GNAS—adrenal gland cancer	0.00185	0.00257	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00185	0.00257	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.00183	0.00254	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ABCB1—adrenal gland cancer	0.00182	0.00252	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00177	0.00245	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00165	0.00229	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.00164	0.00228	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—BAD—adrenal gland cancer	0.00161	0.00224	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00158	0.0022	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—BRAF—adrenal gland cancer	0.00147	0.00204	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TP53—adrenal gland cancer	0.00138	0.00191	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—RRM1—adrenal gland cancer	0.0013	0.0018	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SDHD—adrenal gland cancer	0.0013	0.0018	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00129	0.00179	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—POMC—adrenal gland cancer	0.00125	0.00173	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTGS2—adrenal gland cancer	0.00119	0.00165	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.00106	0.00148	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.00106	0.00148	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CTNNB1—adrenal gland cancer	0.00106	0.00147	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.00106	0.00147	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.00106	0.00147	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—adrenal gland cancer	0.000994	0.00138	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MED12—adrenal gland cancer	0.000967	0.00134	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000865	0.0012	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EGFR—adrenal gland cancer	0.000841	0.00117	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000794	0.0011	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000787	0.00109	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	0.000706	0.00098	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000704	0.000977	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00069	0.000958	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000579	0.000804	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000574	0.000797	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GNAS—adrenal gland cancer	0.000572	0.000794	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000561	0.000779	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	0.000561	0.000779	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000469	0.000652	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000465	0.000646	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000461	0.00064	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000457	0.000634	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—POMC—adrenal gland cancer	0.000385	0.000535	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000316	0.000439	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000313	0.000435	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	0.000307	0.000426	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000252	0.00035	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.00025	0.000347	CbGpPWpGaD
